As European markets navigate the complexities of global bond sell-offs and inflationary pressures, indices like Germany's DAX and France's CAC 40 have experienced declines, while the UK's FTSE 100 showed resilience with a slight gain. In this environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors looking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| VIGO Photonics (WSE:VGO) | PLN486.00 | PLN962.05 | 49.5% |
| RaySearch Laboratories (OM:RAY B) | SEK181.70 | SEK357.36 | 49.2% |
| Nexstim (HLSE:NXTMH) | €9.28 | €18.20 | 49% |
| Mare Group (BIT:MARE) | €5.10 | €10.01 | 49% |
| Gabriel Holding (CPSE:GABR) | DKK262.00 | DKK523.36 | 49.9% |
| F-Secure Oyj (HLSE:FSECURE) | €2.00 | €3.96 | 49.5% |
| Dustin Group (OM:DUST) | SEK1.786 | SEK3.51 | 49.2% |
| Dellia Group (OB:DELIA) | NOK19.26 | NOK38.33 | 49.7% |
| Borregaard (OB:BRG) | NOK156.60 | NOK309.55 | 49.4% |
| Bonesupport Holding (OM:BONEX) | SEK224.40 | SEK442.32 | 49.3% |
Here's a peek at a few of the choices from the screener.
Harvia Oyj (HLSE:HARVIA)
Overview: Harvia Oyj designs, manufactures, and markets a range of sauna products worldwide with a market cap of €842.92 million.
Operations: The company's revenue comes from the Building Materials - HVAC Equipment segment, totaling €210.74 million.
Estimated Discount To Fair Value: 37.9%
Harvia Oyj's recent earnings report shows robust growth, with net income rising to €5.52 million in Q2 2026 from €4.38 million a year ago. The company is trading over 20% below its future cash flow value and at 37.9% below estimated fair value, suggesting it may be undervalued based on cash flows. Additionally, Harvia's strategic partnerships aim to foster innovation and sustainability, potentially enhancing its competitive edge in the market.
- Our expertly prepared growth report on Harvia Oyj implies its future financial outlook may be stronger than recent results.
- Click here to discover the nuances of Harvia Oyj with our detailed financial health report.
Kitron (OB:KIT)
Overview: Kitron ASA is an electronics manufacturing services provider operating in multiple countries, including Norway, Sweden, and the United States, with a market cap of NOK20.07 billion.
Operations: The company generates revenue of €969.90 million from its Electronics Manufacturing Services (EMS) segment.
Estimated Discount To Fair Value: 25%
Kitron ASA's recent earnings guidance revision highlights its strong demand and improved supply chain visibility, projecting 2026 revenue between €1.05 billion and €1.15 billion, up from previous estimates. The company is trading at NOK91.75, below its estimated future cash flow value of NOK122.32, reflecting potential undervaluation based on cash flows. Its earnings are forecast to grow 17.9% annually, outpacing the Norwegian market average of 8.4%, supported by a robust Q2 performance with net income doubling year-over-year to €21.4 million.
- Our growth report here indicates Kitron may be poised for an improving outlook.
- Navigate through the intricacies of Kitron with our comprehensive financial health report here.
Alimak Group (OM:ALIG)
Overview: Alimak Group AB (publ) is a company that designs, manufactures, sells, and services vertical access and working at height solutions globally, with a market capitalization of approximately SEK13.63 billion.
Operations: The company's revenue segments are comprised of Wind (SEK709 million), HS & PS (SEK1.28 billion), Industrial (SEK1.58 billion), Construction (SEK1.39 billion), and Facade Access (SEK1.85 billion).
Estimated Discount To Fair Value: 48.9%
Alimak Group is trading at SEK128.8, significantly below its estimated future cash flow value of SEK251.9, suggesting undervaluation. Despite a dip in recent earnings, with Q2 net income down to SEK167 million from SEK184 million year-over-year, the company forecasts robust annual profit growth of 22.2%, surpassing the Swedish market average. While pursuing acquisitions and maintaining higher leverage, Alimak's revenue is expected to grow at 7.9% annually.
- Upon reviewing our latest growth report, Alimak Group's projected financial performance appears quite optimistic.
- Delve into the full analysis health report here for a deeper understanding of Alimak Group.
Taking Advantage
- Embark on your investment journey to our 217 Undervalued European Stocks Based On Cash Flows selection here.
- Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Ready To Venture Into Other Investment Styles?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com